Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KEVIN D CANNON

Allopathic & Osteopathic Physicians Hospitalist

NPI
1700897022
CMS profile
122867
Location
WILMINGTON, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$1,400.30

14 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $734.46 10
Travel and Lodging $633.57 3
Education $32.27 1

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Boehringer Ingelheim International GmbH $1,243.57 12
Corcept Therapeutics $124.46 1
Novo Nordisk Inc $32.27 1

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KEVIN D CANNON

NPI 1700897022 · CMS profile ID 122867

Allopathic & Osteopathic Physicians / Hospitalist

WILMINGTON, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1700897022?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KEVIN D CANNON, NPI 1700897022, CMS profile ID 122867. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1700897022?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). KEVIN D CANNON, NPI 1700897022, CMS profile ID 122867. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1700897022?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
KEVIN D CANNON, NPI 1700897022, CMS profile ID 122867, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–14 of 14 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1700897022?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

14 matching records · $1,400.30 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 14 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–14 of 14.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Corcept Therapeutics $124.4611/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050843777 CMS
Boehringer Ingelheim International GmbH $50.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331829 CMS
Boehringer Ingelheim International GmbH $117.1110/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331831 CMS
Boehringer Ingelheim International GmbH $145.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331833 CMS
Boehringer Ingelheim International GmbH $145.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331835 CMS
Boehringer Ingelheim International GmbH $258.2310/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331837 CMS
Boehringer Ingelheim International GmbH $40.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331839 CMS
Boehringer Ingelheim International GmbH $40.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331841 CMS
Boehringer Ingelheim International GmbH $50.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331843 CMS
Boehringer Ingelheim International GmbH $50.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331847 CMS
Boehringer Ingelheim International GmbH $40.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017331849 CMS
Boehringer Ingelheim International GmbH $258.2310/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017333333 CMS
Boehringer Ingelheim International GmbH $50.0010/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017334841 CMS
Novo Nordisk Inc $32.2705/12/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001978001 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,301.48 16
PY2021 $20.00 1
PY2022 $58.19 2
PY2023 $1,400.30 14
PY2025 $116.03 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $3,200.00 1
PY2025 Principal investigator $6,407,903.58 738
PY2024 Recipient $12,299.41 13
PY2024 Principal investigator $7,058,469.69 390
PY2023 Recipient $3,980.00 2
PY2023 Principal investigator $7,125,617.33 899
PY2022 Recipient $9,082.00 12
PY2022 Principal investigator $6,929,547.49 979
PY2021 Recipient $14,312.20 61
PY2021 Principal investigator $9,361,495.59 2,459
PY2020 Recipient $233.41 1
PY2020 Principal investigator $5,812,787.31 750
PY2019 Principal investigator $4,820,055.08 826

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2,520 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $12,096.04 12/31/2021 Non-covered Recipient Entity
PMG RESEARCH OF WILMINGTON
Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3-Dose Regimen of V160 Cytomegalovirus CMV Vaccine in Healthy Seronegative Women, 16 to 35 Years of Age No dispute reported 06/30/2026 848761455
Principal investigator 1 Novo Nordisk AS $29.00 12/31/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635509
Principal investigator 1 Novo Nordisk AS $70.00 12/31/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 833635535
Principal investigator 1 Novo Nordisk AS $25.06 12/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428099
Principal investigator 1 Novo Nordisk AS $5,832.58 12/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879373
Principal investigator 1 Novo Nordisk AS $4,511.32 12/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901413
Principal investigator 1 PFIZER INC. $413.83 12/29/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832563973
Principal investigator 1 Janssen Pharmaceuticals, Inc $6,462.00 12/28/2021 Non-covered Recipient Entity
Accellacare Us Inc.
A Study of an Adenovirus Serotype 26 Prefusion Conformation stabilized F Protein Ad26. RSV. preF Based Respiratory Syncytial Virus RSV Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older No dispute reported 06/30/2026 787568489
Principal investigator 1 PFIZER INC. $2,345.38 12/28/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832563259
Principal investigator 1 Novo Nordisk AS $25.06 12/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711627
Principal investigator 1 PFIZER INC. $1,655.32 12/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832558099
Principal investigator 1 PFIZER INC. $7,819.20 12/24/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832558949
Principal investigator 1 Novo Nordisk AS $2,804.34 12/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829755
Principal investigator 1 PFIZER INC. $2,926.80 12/23/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832563239
Principal investigator 1 Novo Nordisk AS $9,688.31 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299307
Principal investigator 1 Novo Nordisk AS $4,468.78 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325203
Principal investigator 1 Novo Nordisk AS $8,430.09 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537141
Principal investigator 1 Novo Nordisk AS $5,155.36 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603247
Principal investigator 1 Novo Nordisk AS $7,930.17 12/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780887
Principal investigator 1 Novo Nordisk AS $78,289.40 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811791543
Principal investigator 1 Novo Nordisk AS $2,638.12 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808739
Principal investigator 1 Novo Nordisk AS $2,861.90 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863147
Principal investigator 1 Novo Nordisk AS $2,565.00 12/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886443
Principal investigator 1 PFIZER INC. $10,916.64 12/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832523901
Principal investigator 1 PFIZER INC. $12,963.51 12/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832523913
Principal investigator 1 PFIZER INC. $37,339.65 12/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832558589
Principal investigator 1 PFIZER INC. $2,581.95 12/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832563249
Principal investigator 1 PFIZER INC. $28,178.55 12/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832563649
Principal investigator 1 Novo Nordisk AS $25.06 12/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810791503
Principal investigator 1 Novo Nordisk AS $25.06 12/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428081
Principal investigator 1 Novo Nordisk AS $25.06 12/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428088
Principal investigator 1 Boehringer Ingelheim France S.A.S. $345.98 12/16/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023577
Recipient Novo Nordisk AS $6.00 12/16/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811721641
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811721665
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811721671
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735719
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735725
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735731
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735837
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735843
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735849
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735937
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736255
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736261
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736267
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736273
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736279
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736285
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736291
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736297
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736301
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736307
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811740243
Principal investigator 1 Novo Nordisk AS $299.80 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811791539
Principal investigator 1 Novo Nordisk AS $299.80 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811791541
Recipient Novo Nordisk AS $6.00 12/16/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811797143
Recipient Novo Nordisk AS $220.00 12/16/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811797157
Recipient Novo Nordisk AS $270.00 12/16/2021 Covered Recipient Physician NN1436-4478 No dispute reported 06/30/2026 811797163
Recipient Novo Nordisk AS $6.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797167
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797171
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800013
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800015
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800017
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800019
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800021
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800023
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800025
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800027
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800061
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800063
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800065
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800067
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800069
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800071
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800073
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800075
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800077
Principal investigator 1 Novo Nordisk AS $299.80 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811880373
Recipient Novo Nordisk AS $270.00 12/16/2021 Covered Recipient Physician NN1436-4479 No dispute reported 06/30/2026 811884513
Recipient Novo Nordisk AS $6.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884515
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884517
Recipient Novo Nordisk AS $200.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884519
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884521
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN1436-4477 No dispute reported 06/30/2026 811884533
Recipient Novo Nordisk AS $240.00 12/16/2021 Covered Recipient Physician NN1436-4477 No dispute reported 06/30/2026 811884535
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886431
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886433
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886435
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886437
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886439
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886523
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886525
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886527
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886529
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886531
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886533
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886535
Principal investigator 1 Novo Nordisk AS $299.80 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901297
Principal investigator 1 Novo Nordisk AS $299.80 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901307
Recipient Novo Nordisk AS $270.00 12/16/2021 Covered Recipient Physician NN1436-4478 No dispute reported 06/30/2026 811904113
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905401
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905403
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905405
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905407
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905409
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905411
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905441
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905443
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905445
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905447
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905449
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905451
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905453
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905455
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905457
Principal investigator 1 Novo Nordisk AS $74.85 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905459
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905461
Principal investigator 1 Novo Nordisk AS $32.50 12/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905463
Principal investigator 1 Novo Nordisk AS $78.84 12/15/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871395
Principal investigator 1 Novo Nordisk AS $12.00 12/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811691113
Principal investigator 1 Novo Nordisk AS $609.00 12/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735855
Principal investigator 1 Novo Nordisk AS $1,270.00 12/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800029
Principal investigator 1 Novo Nordisk AS $3,000.00 12/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886441
Principal investigator 1 PFIZER INC. $38,871.36 12/10/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832523893
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127943
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127957
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128545
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128555
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128689
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128701
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128935
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128949
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128963
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128977
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128989
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811129003
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811129015
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465265
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465275
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465285
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465295
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465305
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465315
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465325
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465331
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465341
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465571
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465581
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465591
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465601
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465611
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465621
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465743
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465783
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465791
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465799
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465809
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465819
Recipient Novo Nordisk AS $200.00 12/09/2021 Covered Recipient Physician NN9838-4862 No dispute reported 06/30/2026 811721647
Recipient Novo Nordisk AS $220.00 12/09/2021 Covered Recipient Physician NN1436-4478 No dispute reported 06/30/2026 811721653
Recipient Novo Nordisk AS $200.00 12/09/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811721659
Recipient Novo Nordisk AS $270.00 12/09/2021 Covered Recipient Physician NN9838-4862 No dispute reported 06/30/2026 811797149
Recipient Novo Nordisk AS $220.00 12/09/2021 Covered Recipient Physician NN9838-4862 No dispute reported 06/30/2026 811797151
Recipient Novo Nordisk AS $200.00 12/09/2021 Covered Recipient Physician NN1436-4479 No dispute reported 06/30/2026 811797165
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808401
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808403
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808405
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808407
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808607
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808609
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808611
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808613
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808615
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808617
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808619
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808621
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808623
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808685
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808687
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808733
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808735
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808737
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808741
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808743
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808745
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808747
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808749
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842035
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842037
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842039
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842057
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842059
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842119
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842121
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842123
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842133
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842135
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842137
Principal investigator 1 Novo Nordisk AS $11.38 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842139
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842141
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842143
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842183
Principal investigator 1 Novo Nordisk AS $100.00 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842185
Principal investigator 1 Novo Nordisk AS $9.98 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811843213
Recipient Novo Nordisk AS $200.00 12/09/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811904105
Recipient Novo Nordisk AS $220.00 12/09/2021 Covered Recipient Physician NN9838-4862 No dispute reported 06/30/2026 811904109
Recipient Novo Nordisk AS $220.00 12/09/2021 Covered Recipient Physician NN1436-4479 No dispute reported 06/30/2026 811904117
Recipient Novo Nordisk AS $240.00 12/09/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811904121
Principal investigator 1 Novo Nordisk AS $143.55 12/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905439
Principal investigator 1 Novo Nordisk AS $25.06 12/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299327
Principal investigator 1 Novo Nordisk AS $24.56 12/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867891
Principal investigator 1 PFIZER INC. $1,893.43 12/08/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832558943
Principal investigator 1 Novo Nordisk AS $25.06 12/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711617
Principal investigator 1 PFIZER INC. $413.83 12/07/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832558583
Principal investigator 1 PFIZER INC. $18,064.35 12/07/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832558933
Principal investigator 1 PFIZER INC. $743.85 12/07/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832563957
Principal investigator 1 PFIZER INC. $6,480.00 12/07/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832563965
Principal investigator 1 Novo Nordisk AS $26.00 12/06/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894295
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721065
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721072
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721081
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721091
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721101
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721111
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721121
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721129
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721185
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721193
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721203
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721213
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721223
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721233
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721241
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721252
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798949
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798960
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798969
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798979
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799035
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799045
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799055
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799065
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799073
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799083
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799093
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799103
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799113
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799161
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799171
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799181
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799191
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799201
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799211
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799221
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799231
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810801887
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810801897
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810801907
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811321997
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322349
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322357
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322365
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322373
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322381
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322391
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322401
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322411
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322421
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322429
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322437
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325117
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325123
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325134
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325143
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325153
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325163
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325173
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325183
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325193
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811331357
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469045
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469051
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469061
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469123
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469131
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469139
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469149
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469285
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469291
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469301
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469311
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469321
Principal investigator 1 Novo Nordisk AS $39.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469361
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469371
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469379
Principal investigator 1 Novo Nordisk AS $11.38 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811480665
Principal investigator 1 Novo Nordisk AS $3,000.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811880369
Principal investigator 1 Novo Nordisk AS $609.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901299
Principal investigator 1 Novo Nordisk AS $1,270.00 12/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901301
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242019
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242027
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242055
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242101
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242111
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242453
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242461
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242471
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536853
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536863
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536873
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536883
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536889
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536899
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536909
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536919
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536945
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536955
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536965
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536975
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536985
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811537005
Recipient Novo Nordisk AS $270.00 12/02/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811797153
Recipient Novo Nordisk AS $270.00 12/02/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811797155
Recipient Novo Nordisk AS $270.00 12/02/2021 Covered Recipient Physician NN1436-4478 No dispute reported 06/30/2026 811797161
Recipient Novo Nordisk AS $200.00 12/02/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797169
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833879
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833881
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833883
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833885
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833889
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857811
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857813
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857823
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857829
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857831
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857833
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857835
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857837
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857839
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857841
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857843
Principal investigator 1 Novo Nordisk AS $9.75 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857845
Principal investigator 1 Novo Nordisk AS $22.86 12/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900921
Recipient Novo Nordisk AS $200.00 12/02/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811904119
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023565
Principal investigator 1 Boehringer Ingelheim France S.A.S. $90.65 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023567
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023581
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023583
Principal investigator 1 Boehringer Ingelheim France S.A.S. $77.46 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023757
Principal investigator 1 Boehringer Ingelheim France S.A.S. $90.65 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023759
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023761
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023765
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023767
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023769
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023771
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023773
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023775
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023777
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023779
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023781
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023783
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023785
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023787
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.31 12/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023789
Principal investigator 1 Novo Nordisk AS $875.20 12/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833893
Principal investigator 1 Novo Nordisk AS $14,117.66 12/01/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871399
Principal investigator 1 Novo Nordisk AS $8,387.07 12/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890905
Principal investigator 1 Novo Nordisk AS $2,560.79 12/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900847
Principal investigator 1 PFIZER INC. $1,456.76 12/01/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832558107
Principal investigator 1 Novo Nordisk AS $29.00 11/30/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635513
Principal investigator 1 Novo Nordisk AS $70.00 11/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 833635539
Principal investigator 1 PFIZER INC. $743.85 11/30/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF 07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832828697
Principal investigator 1 PFIZER INC. $743.85 11/30/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832904191
Principal investigator 1 Novo Nordisk AS $10,084.27 11/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811010557
Principal investigator 1 Novo Nordisk AS $7,473.55 11/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595987
Principal investigator 1 Novo Nordisk AS $297.00 11/28/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635505
Principal investigator 1 Novo Nordisk AS $297.00 11/28/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635507
Principal investigator 1 Novo Nordisk AS $297.00 11/28/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635515
Principal investigator 1 Novo Nordisk AS $297.00 11/28/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635517
Principal investigator 1 Novo Nordisk AS $6,458.78 11/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469071
Recipient Novo Nordisk AS $200.00 11/24/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811797145
Recipient Novo Nordisk AS $175.00 11/24/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811797159
Recipient Novo Nordisk AS $240.00 11/24/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797175
Principal investigator 1 Novo Nordisk AS $4,435.02 11/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798763
Recipient Novo Nordisk AS $240.00 11/24/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811884507
Recipient Novo Nordisk AS $75.00 11/24/2021 Covered Recipient Physician NN9535-4321 No dispute reported 06/30/2026 811884509
Recipient Novo Nordisk AS $175.00 11/24/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811884511
Recipient Novo Nordisk AS $270.00 11/24/2021 Covered Recipient Physician NN1436-4477 No dispute reported 06/30/2026 811884537
Recipient Novo Nordisk AS $125.00 11/24/2021 Covered Recipient Physician NN1436-4477 No dispute reported 06/30/2026 811884539
Recipient Novo Nordisk AS $240.00 11/24/2021 Covered Recipient Physician NN9924-4635 No dispute reported 06/30/2026 811904111
Recipient Novo Nordisk AS $240.00 11/24/2021 Covered Recipient Physician NN1436-4478 No dispute reported 06/30/2026 811904115
Recipient Novo Nordisk AS $220.00 11/24/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811904125
Principal investigator 1 PFIZER INC. $172.13 11/24/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832624591
Principal investigator 1 PFIZER INC. $1,969.87 11/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832691765
Principal investigator 1 PFIZER INC. $24,590.25 11/23/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832617549
Principal investigator 1 PFIZER INC. $162,055.35 11/23/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832617569
Principal investigator 1 Novo Nordisk AS $25.06 11/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711580
Principal investigator 1 Novo Nordisk AS $23.06 11/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413013
Principal investigator 1 PFIZER INC. $22,511.36 11/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832518459
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811721677
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811721683
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797173
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811797177
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9536-4578 No dispute reported 06/30/2026 811797251
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884523
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884525
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884527
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884529
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811884531
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9536-4578 No dispute reported 06/30/2026 811884545
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9536-4578 No dispute reported 06/30/2026 811884547
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811904123
Recipient Novo Nordisk AS $6.00 11/18/2021 Covered Recipient Physician NN9924-4473 No dispute reported 06/30/2026 811904127
Recipient Novo Nordisk AS $12.00 11/18/2021 Covered Recipient Physician NN9536-4578 No dispute reported 06/30/2026 811904129
Principal investigator 1 PFIZER INC. $1,181.56 11/18/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832700129
Principal investigator 1 PFIZER INC. $2,673.00 11/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604635
Principal investigator 1 PFIZER INC. $2,231.55 11/16/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF 07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832804053
Principal investigator 1 PFIZER INC. $3,441.69 11/16/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832845641
Principal investigator 1 Novo Nordisk AS $50.12 11/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413003
Principal investigator 1 Novo Nordisk AS $25.06 11/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428021
Principal investigator 1 Novo Nordisk AS $49.75 11/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901305
Principal investigator 1 GlaxoSmithKline, LLC. $2,325.12 11/11/2021 Non-covered Recipient Entity
PMG RESEARCH LLC
Not supplied No dispute reported 06/30/2026 809515441
Principal investigator 1 Novo Nordisk AS $1,485.00 11/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 833635527
Principal investigator 1 Novo Nordisk AS $594.00 11/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 833635529
Principal investigator 1 Novo Nordisk AS $1,485.00 11/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 833635531
Principal investigator 1 Novo Nordisk AS $594.00 11/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 833635533
Principal investigator 1 Novo Nordisk AS $23.06 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299281
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735629
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735635
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735641
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735647
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735653
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735659
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735665
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735671
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735677
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735683
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735689
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735877
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735883
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735889
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735895
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735901
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735907
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735914
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736349
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736355
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799983
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799985
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799987
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799989
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799991
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799993
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799995
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799997
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799999
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800035
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800037
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800039
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800041
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800043
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800045
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800047
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800049
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800087
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886303
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886409
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886411
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886413
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886415
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886417
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886419
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886421
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886423
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886493
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886495
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886497
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886499
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886501
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886503
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886505
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886507
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886509
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886545
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886547
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886549
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886551
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905373
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905375
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905377
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905379
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905381
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905383
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905385
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905387
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905389
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905423
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905425
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905427
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905429
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905431
Principal investigator 1 Novo Nordisk AS $11.40 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905475
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905477
Principal investigator 1 Novo Nordisk AS $22.76 11/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905479
Principal investigator 1 PFIZER INC. $5,300.64 11/10/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832517605
Principal investigator 1 PFIZER INC. $827.66 11/10/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832774941
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735695
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735701
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735707
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735713
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735919
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735925
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735931
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736781
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800001
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800003
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800005
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800007
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800009
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800011
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800051
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800053
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800055
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800057
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800059
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800413
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886425
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886427
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886429
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886511
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886513
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886515
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886517
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886519
Principal investigator 1 Novo Nordisk AS $1.97 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886521
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886553
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886555
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905391
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905393
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905395
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905397
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905399
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905433
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905435
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905437
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905481
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905483
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905485
Principal investigator 1 Novo Nordisk AS $3.05 11/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905487
Principal investigator 1 PFIZER INC. $2,697.84 11/09/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF 07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832702527
Principal investigator 1 PFIZER INC. $20,504.61 11/09/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832727059
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758353
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758359
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758365
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758370
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758375
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758381
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758387
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758393
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758399
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758405
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758411
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758417
Principal investigator 1 Novo Nordisk AS $8.00 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758423
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758429
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758435
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758439
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758445
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811758545
Principal investigator 1 Novo Nordisk AS $3,000.00 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791811
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801955
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801957
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801959
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801961
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801963
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801965
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801967
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801969
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801971
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801973
Principal investigator 1 Novo Nordisk AS $5.70 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801975
Principal investigator 1 Novo Nordisk AS $6.50 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801977
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801979
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801981
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811801983
Principal investigator 1 Novo Nordisk AS $25.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879507
Principal investigator 1 Novo Nordisk AS $500.00 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880671
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895325
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895327
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895329
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895331
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895333
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895335
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895337
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895339
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895341
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895343
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895345
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895347
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895349
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895351
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895353
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895355
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895357
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895359
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895361
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895363
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895365
Principal investigator 1 Novo Nordisk AS $22.80 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895367
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895405
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895407
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811895409
Principal investigator 1 Novo Nordisk AS $25.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900919
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907333
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907335
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907337
Principal investigator 1 Novo Nordisk AS $1.95 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907339
Principal investigator 1 Novo Nordisk AS $2.96 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907341
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907343
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907345
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907347
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907349
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907351
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907353
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907355
Principal investigator 1 Novo Nordisk AS $9.98 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907357
Principal investigator 1 Novo Nordisk AS $39.90 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907359
Principal investigator 1 Novo Nordisk AS $9.74 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907361
Principal investigator 1 Novo Nordisk AS $40.00 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907363
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907365
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907367
Principal investigator 1 Novo Nordisk AS $3.05 11/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1535-4593 No dispute reported 06/30/2026 811907369
Principal investigator 1 PFIZER INC. $670.95 11/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600945
Principal investigator 1 PFIZER INC. $10,682.55 11/05/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832616945
Principal investigator 1 PFIZER INC. $1,450.00 11/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832695737
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292787
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292795
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292805
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595273
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595283
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837257
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837259
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863017
Principal investigator 1 Novo Nordisk AS $100.00 11/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863359
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686285
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686289
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686295
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686301
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686307
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686313
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686317
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686323
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686329
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686335
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686793
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686799
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686811
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686817
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686823
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686829
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687169
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687491
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687497
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790111
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790113
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790187
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790189
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790191
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790193
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790195
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790197
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790223
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790225
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790227
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790229
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790231
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790233
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790235
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790239
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790241
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790243
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790245
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790247
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790249
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790251
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790253
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790399
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790401
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790403
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790443
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790445
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790447
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879219
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879221
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879223
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879225
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879227
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879229
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879231
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879233
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879235
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879237
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879291
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879293
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879295
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879301
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879303
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879305
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879307
Principal investigator 1 Novo Nordisk AS $46.35 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879309
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879311
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879313
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879315
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879317
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879319
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879321
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879323
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879361
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879363
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879365
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879367
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879369
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879371
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879439
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879441
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879463
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879465
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879467
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879469
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900769
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900771
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900773
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900775
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900777
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900779
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900781
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900783
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900785
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900787
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900789
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900791
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900793
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900795
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900797
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900817
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900819
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900827
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900829
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900831
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900833
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900835
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900837
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900839
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900841
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900843
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900845
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900893
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900895
Principal investigator 1 Novo Nordisk AS $17.10 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900913
Principal investigator 1 Novo Nordisk AS $22.76 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900915
Principal investigator 1 Novo Nordisk AS $13.00 11/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900917
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023573
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023605
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023607
Principal investigator 1 Boehringer Ingelheim France S.A.S. $92.46 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023619
Principal investigator 1 Boehringer Ingelheim France S.A.S. $79.00 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023621
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023629
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023631
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023633
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023635
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023637
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023639
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023641
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023643
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023645
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023647
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023649
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023651
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023653
Principal investigator 1 Boehringer Ingelheim France S.A.S. $33.98 11/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023655
Principal investigator 1 PFIZER INC. $3,328.38 10/30/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832822027
Principal investigator 1 Novo Nordisk AS $3,442.52 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322305
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693189
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790385
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791805
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791807
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791809
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900887
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900889
Principal investigator 1 Novo Nordisk AS $27.96 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900911
Principal investigator 1 Novo Nordisk AS $29.00 10/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 833635511
Principal investigator 1 Novo Nordisk AS $70.00 10/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 833635537
Principal investigator 1 PFIZER INC. $270.00 10/29/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832616935
Principal investigator 1 PFIZER INC. $51,444.45 10/29/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF 07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832691323
Principal investigator 1 Novo Nordisk AS $75.00 10/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900891
Principal investigator 1 Novo Nordisk AS $3,377.82 10/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099089
Principal investigator 1 Novo Nordisk AS $875.20 10/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242071
Principal investigator 1 Novo Nordisk AS $1,116.85 10/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299301
Principal investigator 1 Novo Nordisk AS $187.50 10/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536995
Principal investigator 1 Novo Nordisk AS $3,489.48 10/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650665
Principal investigator 1 Novo Nordisk AS $1,765.83 10/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837323
Principal investigator 1 PFIZER INC. $4,709.53 10/27/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832866069
Principal investigator 1 Boehringer Ingelheim France S.A.S. $1,773.73 10/26/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023815
Principal investigator 1 Novo Nordisk AS $23.06 10/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428011
Principal investigator 1 Novo Nordisk AS $73.20 10/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811691107
Principal investigator 1 Novo Nordisk AS $73.20 10/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811880371
Principal investigator 1 Novo Nordisk AS $73.20 10/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811901303
Principal investigator 1 PFIZER INC. $10,000.00 10/26/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 23 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332RITONAVIR IN PREVENTING SYMPTOMATIC SARSCOV2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID19 No dispute reported 06/30/2026 832623583
Principal investigator 1 PFIZER INC. $3,145.23 10/26/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832706479
Principal investigator 1 Novo Nordisk AS $25.06 10/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811412995
Principal investigator 1 Novo Nordisk AS $4,672.26 10/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537131
Principal investigator 1 Novo Nordisk AS $3,000.00 10/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603237
Principal investigator 1 Novo Nordisk AS $5,507.24 10/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770431
Principal investigator 1 Novo Nordisk AS $95.40 10/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650647
Principal investigator 1 Novo Nordisk AS $95.40 10/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650653
Principal investigator 1 Novo Nordisk AS $95.40 10/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894289
Principal investigator 1 Novo Nordisk AS $95.40 10/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894291
Principal investigator 1 Novo Nordisk AS $95.40 10/22/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894293
Principal investigator 1 PFIZER INC. $8,820.00 10/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832517615
Principal investigator 1 PFIZER INC. $2,000.00 10/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF 3 LOTS OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832517625
Principal investigator 1 PFIZER INC. $670.95 10/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832599637
Principal investigator 1 PFIZER INC. $7,566.75 10/21/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832616963
Principal investigator 1 PFIZER INC. $37,906.50 10/21/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832775271
Principal investigator 1 Novo Nordisk AS $23.06 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428001
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735583
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735589
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735595
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735599
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735605
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735611
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735617
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735623
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735861
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735865
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811735871
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736313
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736319
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736325
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736331
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736337
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811736343
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811740249
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799977
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799979
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811799981
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800031
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800033
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800079
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800081
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800083
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811800085
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886293
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886295
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886297
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886299
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886301
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886483
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886485
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886487
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886489
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886491
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886537
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886539
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886541
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811886543
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905363
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905365
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905367
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905369
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905371
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905413
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905415
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905417
Principal investigator 1 Novo Nordisk AS $70.44 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905419
Principal investigator 1 Novo Nordisk AS $21.64 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905421
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905465
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905467
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905469
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905471
Principal investigator 1 Novo Nordisk AS $13.00 10/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9775-4708 No dispute reported 06/30/2026 811905473
Principal investigator 1 Novo Nordisk AS $27.90 10/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811700185
Principal investigator 1 PFIZER INC. $8,618.40 10/19/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832862092
Principal investigator 1 Novo Nordisk AS $23.06 10/18/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711569
Principal investigator 1 PFIZER INC. $5,300.31 10/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832703433
Principal investigator 1 GlaxoSmithKline, LLC. $89,936.39 10/15/2021 Non-covered Recipient Entity
PMG RESEARCH LLC
Not supplied No dispute reported 06/30/2026 809523339
Principal investigator 1 GlaxoSmithKline, LLC. $46,129.49 10/15/2021 Non-covered Recipient Entity
PMG RESEARCH LLC
Not supplied No dispute reported 06/30/2026 809540319
Principal investigator 1 Novo Nordisk AS $23.06 10/15/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299271
Principal investigator 1 PFIZER INC. $3,533.49 10/13/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832763739
Principal investigator 1 PFIZER INC. $10,000.00 10/13/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2 ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF 07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT LOW RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832894815
Principal investigator 1 GlaxoSmithKline, LLC. $6,500.00 10/11/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE I/II OBSERVER-BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTI-CEN No dispute reported 06/30/2026 860871397
Principal investigator 1 PFIZER INC. $668.25 10/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600117
Principal investigator 1 PFIZER INC. $17,982.92 10/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832749659
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721005
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721015
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721035
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721045
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721054
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721147
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721157
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721165
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721175
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798989
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810798999
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799009
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799019
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799029
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799141
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799151
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810801877
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811321969
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811321977
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811321987
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322313
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322323
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322331
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322341
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322454
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322463
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325097
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811325107
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811331367
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469025
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469035
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469079
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469087
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469097
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469103
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469113
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469341
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469348
Principal investigator 1 Novo Nordisk AS $28.45 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811480433
Principal investigator 1 Novo Nordisk AS $2,500.00 10/08/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650659
Principal investigator 1 Novo Nordisk AS $3,000.00 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686835
Principal investigator 1 Novo Nordisk AS $1,000.00 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686841
Principal investigator 1 Novo Nordisk AS $600.00 10/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687503
Principal investigator 1 Novo Nordisk AS $609.00 10/08/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780883
Principal investigator 1 Novo Nordisk AS $3,000.00 10/08/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780885
Principal investigator 1 Novo Nordisk AS $1,270.00 10/08/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871397
Principal investigator 1 Novo Nordisk AS $250.00 10/08/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894297
Principal investigator 1 PFIZER INC. $18,160.20 10/08/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832616925
Principal investigator 1 PFIZER INC. $8,005.50 10/08/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832617967
Principal investigator 1 Novo Nordisk AS $49.12 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804981
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292679
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292689
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292759
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292769
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292777
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293425
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293435
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293443
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293453
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293459
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595217
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595227
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595237
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595247
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595263
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595957
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595967
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595977
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837237
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837251
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837253
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837255
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837319
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837321
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863013
Principal investigator 1 Novo Nordisk AS $14.97 10/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863015
Principal investigator 1 Novo Nordisk AS $23.06 10/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810713645
Principal investigator 1 Novo Nordisk AS $1,650.00 10/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 833635521
Principal investigator 1 Novo Nordisk AS $330.00 10/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 833635525
Principal investigator 1 PFIZER INC. $6,889.77 10/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832774641
Principal investigator 1 PFIZER INC. $5,172.12 10/05/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832917165
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650165
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650171
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650175
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650181
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650617
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650623
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650629
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650635
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650641
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650953
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652171
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652177
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652183
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652188
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652195
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652199
Principal investigator 1 Novo Nordisk AS $14.63 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652549
Principal investigator 1 Novo Nordisk AS $12.25 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652555
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780865
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780867
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780869
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780871
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780873
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780875
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780877
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780879
Principal investigator 1 Novo Nordisk AS $18.00 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780881
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780977
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780979
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780981
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781083
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781085
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781087
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781089
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781091
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781093
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781095
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781097
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781099
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781101
Principal investigator 1 Novo Nordisk AS $2.85 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781103
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781113
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871379
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871381
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871383
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871385
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871387
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871389
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871391
Principal investigator 1 Novo Nordisk AS $4.50 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871393
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871459
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871461
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871463
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871465
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871467
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871469
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871471
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871473
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871475
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871477
Principal investigator 1 Novo Nordisk AS $4.50 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871479
Principal investigator 1 Novo Nordisk AS $30.00 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871481
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871487
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871489
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894273
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894275
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894277
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894279
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894281
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894283
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894285
Principal investigator 1 Novo Nordisk AS $3.25 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894287
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894343
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894345
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894347
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894349
Principal investigator 1 Novo Nordisk AS $4.99 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894351
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894353
Principal investigator 1 Novo Nordisk AS $10.82 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894355
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894357
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894359
Principal investigator 1 Novo Nordisk AS $11.38 10/04/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894361
Principal investigator 1 Novo Nordisk AS $4,950.00 10/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 833635519
Principal investigator 1 Novo Nordisk AS $330.00 10/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 833635523
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023569
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023589
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023591
Principal investigator 1 Boehringer Ingelheim France S.A.S. $26.89 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023609
Principal investigator 1 Boehringer Ingelheim France S.A.S. $79.12 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023623
Principal investigator 1 Boehringer Ingelheim France S.A.S. $92.59 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023625
Principal investigator 1 Boehringer Ingelheim France S.A.S. $92.59 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023627
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023675
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023677
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023719
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023721
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023723
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023725
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023727
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023729
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023731
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023747
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023749
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023751
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023753
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.03 10/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023755
Principal investigator 1 PFIZER INC. $24,057.00 10/01/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832695581
Principal investigator 1 Novo Nordisk AS $29.00 09/30/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781081
Principal investigator 1 Novo Nordisk AS $70.00 09/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829773
Principal investigator 1 PFIZER INC. $10,000.00 09/30/2021 Non-covered Recipient Entity
Accellacare US Inc
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832738055
Principal investigator 1 Novo Nordisk AS $1,123.07 09/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242065
Principal investigator 1 Novo Nordisk AS $23.06 09/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299251
Principal investigator 1 Novo Nordisk AS $25.06 09/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413024
Recipient Regeneron Pharmaceuticals, Inc. $142.20 09/29/2021 Covered Recipient Physician A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793081709
Principal investigator 1 Boehringer Ingelheim France S.A.S. $1,908.67 09/27/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023795
Principal investigator 1 Novo Nordisk AS $4,919.82 09/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789151
Principal investigator 1 Novo Nordisk AS $3,912.17 09/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099075
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652153
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652159
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652165
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781001
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781003
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781005
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781079
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781109
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781111
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871453
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871455
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871457
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811877773
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894335
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894337
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894339
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894371
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894373
Principal investigator 1 Novo Nordisk AS $4.99 09/27/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894375
Principal investigator 1 PFIZER INC. $12,012.10 09/25/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832778975
Principal investigator 1 Novo Nordisk AS $10,035.69 09/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721025
Principal investigator 1 Novo Nordisk AS $11,287.24 09/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804991
Principal investigator 1 Novo Nordisk AS $663.12 09/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293773
Principal investigator 1 Novo Nordisk AS $4,590.00 09/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465829
Principal investigator 1 Novo Nordisk AS $5,891.82 09/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595293
Principal investigator 1 Novo Nordisk AS $20.25 09/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829757
Principal investigator 1 PFIZER INC. $1,154.25 09/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604193
Principal investigator 1 PFIZER INC. $8,000.00 09/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 2B PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A HEXAVALENT GROUP B STREPTOCOCCUS VACCINE WHEN ADMINISTERED CONCOMITANTLY WITH TETANUS DIPHTHERIA AND ACELLULAR PERTUSSIS VACCINE TDAP IN HEALTHY NONPREGNANT WOMEN 18 THROUGH 49 YEARS OF AGE No dispute reported 06/30/2026 832617559
Principal investigator 1 PFIZER INC. $10,820.00 09/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 832617597
Principal investigator 1 PFIZER INC. $8,147.24 09/21/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832715605
Principal investigator 1 Novo Nordisk AS $23.06 09/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711541
Principal investigator 1 PFIZER INC. $920.00 09/20/2021 Non-covered Recipient Entity
ACCELLACARE
A PHASE 23 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332RITONAVIR IN PREVENTING SYMPTOMATIC SARSCOV2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID19 No dispute reported 06/30/2026 832581327
Principal investigator 1 PFIZER INC. $113.80 09/20/2021 Non-covered Recipient Entity
ACCELLACARE
A PHASE 23 RANDOMIZED DOUBLEBLIND DOUBLEDUMMY PLACEBO CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF 2 REGIMENS OF ORALLY ADMINISTERED PF 07321332RITONAVIR IN PREVENTING SYMPTOMATIC SARSCOV2 INFECTION IN ADULT HOUSEHOLD CONTACTS OF AN INDIVIDUAL WITH SYMPTOMATIC COVID19 No dispute reported 06/30/2026 832581621
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $19,420.83 09/20/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793110329
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $31,349.88 09/20/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793110331
Principal investigator 1 Novo Nordisk AS $23.06 09/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711551
Principal investigator 1 Novo Nordisk AS $23.06 09/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299241
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292739
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292749
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595937
Principal investigator 1 Novo Nordisk AS $27.90 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811691101
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837247
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837249
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837311
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863007
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863009
Principal investigator 1 Novo Nordisk AS $320.00 09/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863011
Principal investigator 1 PFIZER INC. $35,214.75 09/15/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832618577
Principal investigator 1 PFIZER INC. $7,288.95 09/14/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832754053
Principal investigator 1 Novo Nordisk AS $23.06 09/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810791475
Principal investigator 1 Novo Nordisk AS $30.00 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650941
Principal investigator 1 Novo Nordisk AS $18.00 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652147
Principal investigator 1 Novo Nordisk AS $4.50 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780973
Principal investigator 1 Novo Nordisk AS $4.50 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780975
Principal investigator 1 Novo Nordisk AS $23.06 09/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798803
Principal investigator 1 Novo Nordisk AS $3.25 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871425
Principal investigator 1 Novo Nordisk AS $2.65 09/10/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894319
Principal investigator 1 Novo Nordisk AS $1,980.00 09/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804961
Principal investigator 1 Novo Nordisk AS $23.06 09/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857819
Principal investigator 1 Novo Nordisk AS $23.46 09/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810791465
Principal investigator 1 PFIZER INC. $540.00 09/08/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600497
Principal investigator 1 PFIZER INC. $23,492.14 09/08/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832778965
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686261
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686267
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686273
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686279
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686341
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686345
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686745
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686751
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686757
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686763
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686769
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686775
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686781
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686787
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686805
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687067
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687073
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687079
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687085
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687091
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687097
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687103
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687109
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687115
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687121
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687127
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687133
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687139
Principal investigator 1 Novo Nordisk AS $25.98 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687145
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687151
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691819
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691825
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691831
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691837
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691843
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691849
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691855
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691861
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691867
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811691873
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693101
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693107
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693113
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693119
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693123
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693129
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693135
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693141
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693147
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693153
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693159
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693165
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693171
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693177
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693195
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693201
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693207
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693761
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693765
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693771
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693777
Principal investigator 1 Novo Nordisk AS $9.99 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693783
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693789
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693797
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693801
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693807
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693813
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693821
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693825
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693831
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693837
Principal investigator 1 Novo Nordisk AS $7.70 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790093
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790095
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790097
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790099
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790101
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790103
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790105
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790107
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790109
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790199
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790201
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790203
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790205
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790207
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790209
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790211
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790213
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790215
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790217
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790219
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790221
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790237
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790255
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790257
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790369
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790371
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790373
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790375
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790377
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790379
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790381
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790383
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790387
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790389
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790391
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790393
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790395
Principal investigator 1 Novo Nordisk AS $25.98 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811790397
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791725
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791727
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791729
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791733
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791735
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791737
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791739
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791775
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791777
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791779
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791781
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791783
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791785
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791787
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791789
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791791
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791793
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791795
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791797
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791799
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791801
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791803
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791847
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791849
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791851
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791853
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791855
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791857
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791859
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791861
Principal investigator 1 Novo Nordisk AS $1.95 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791863
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791865
Principal investigator 1 Novo Nordisk AS $5.56 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791867
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791869
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791871
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791873
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791875
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791877
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791879
Principal investigator 1 Novo Nordisk AS $1.95 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879161
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879163
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879165
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879167
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879169
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879171
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879173
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879175
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879177
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879215
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879217
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879239
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879241
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879243
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879245
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879247
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879249
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879289
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879297
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879299
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879375
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879377
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879379
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879381
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879383
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879385
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879387
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879389
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879391
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879393
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879395
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879435
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879437
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879443
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879445
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879447
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879449
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879451
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879453
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879455
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879457
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879459
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811879461
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880581
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880583
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880585
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880587
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880589
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880591
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880593
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880595
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880597
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880599
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880601
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880603
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880639
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880641
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880643
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880645
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880647
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880649
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880651
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880653
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880655
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880657
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880659
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880661
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880663
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880665
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880667
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880669
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880673
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880675
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880711
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880713
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880715
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880717
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880719
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880721
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880723
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880725
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880727
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880729
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880731
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880733
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880735
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880737
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880739
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880741
Principal investigator 1 Novo Nordisk AS $25.98 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880743
Principal investigator 1 Novo Nordisk AS $25.98 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880745
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811881709
Principal investigator 1 Novo Nordisk AS $9.99 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900741
Principal investigator 1 Novo Nordisk AS $4.16 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900743
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900745
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900747
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900749
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900751
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900753
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900755
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900757
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900759
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900761
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900763
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900765
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900767
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900799
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900801
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900803
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900805
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900807
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900809
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900811
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900813
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900815
Principal investigator 1 Novo Nordisk AS $5.56 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900821
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900823
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900825
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900851
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900853
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900855
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900857
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900859
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900861
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900863
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900865
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900867
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900869
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900871
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900873
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900875
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900877
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900879
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900881
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900883
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900885
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900897
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900899
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900901
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900903
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900905
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900907
Principal investigator 1 Novo Nordisk AS $30.90 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900909
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901385
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901387
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901389
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901391
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901393
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901395
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901397
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901399
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901401
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901403
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901405
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901407
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901409
Principal investigator 1 Novo Nordisk AS $11.38 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901411
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901415
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901417
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901419
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901421
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901423
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901425
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901427
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901429
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901431
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901433
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901435
Principal investigator 1 Novo Nordisk AS $3.05 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901437
Principal investigator 1 Novo Nordisk AS $7.70 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901439
Principal investigator 1 Novo Nordisk AS $27.96 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901441
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901443
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901445
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901447
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901449
Principal investigator 1 Novo Nordisk AS $5.30 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901451
Principal investigator 1 Novo Nordisk AS $30.90 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901453
Principal investigator 1 Novo Nordisk AS $6.50 09/03/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901893
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $12,293.61 09/02/2021 Non-covered Recipient Entity
Valley Weight Loss Clinic
Ph IIb dose finding vs placebo in patients with Ob No dispute reported 06/30/2026 840492763
Principal investigator 1 Novo Nordisk AS $23.06 09/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413043
Principal investigator 1 Novo Nordisk AS $23.06 09/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829767
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023585
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023587
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023593
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023595
Principal investigator 1 Boehringer Ingelheim France S.A.S. $94.48 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023611
Principal investigator 1 Boehringer Ingelheim France S.A.S. $80.73 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023663
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023707
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023709
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023711
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023713
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023715
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023717
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023733
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023735
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023737
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023739
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023741
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023743
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.72 09/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023745
Principal investigator 1 Novo Nordisk AS $23.06 09/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810713635
Principal investigator 1 Novo Nordisk AS $23.06 09/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242045
Principal investigator 1 Novo Nordisk AS $5.25 09/01/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894317
Principal investigator 1 PFIZER INC. $4,200.00 09/01/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832616981
Principal investigator 1 Novo Nordisk AS $70.00 08/31/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099153
Principal investigator 1 Novo Nordisk AS $29.00 08/31/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894321
Principal investigator 1 PFIZER INC. $6,468.25 08/31/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832774651
Principal investigator 1 Novo Nordisk AS $17,471.21 08/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811216705
Principal investigator 1 Novo Nordisk AS $4,868.78 08/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811322447
Principal investigator 1 Novo Nordisk AS $1,000.00 08/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811751027
Principal investigator 1 Novo Nordisk AS $500.00 08/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811751033
Principal investigator 1 Novo Nordisk AS $1,215.49 08/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687163
Principal investigator 1 Novo Nordisk AS $1,215.49 08/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811901455
Principal investigator 1 PFIZER INC. $58,364.55 08/27/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832618597
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $382.80 08/26/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830756043
Principal investigator 1 Boehringer Ingelheim France S.A.S. $2,124.14 08/26/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023793
Principal investigator 1 Novo Nordisk AS $990.00 08/26/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650947
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $8.20 08/25/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830750871
Principal investigator 1 Novo Nordisk AS $2,889.49 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711561
Principal investigator 1 Novo Nordisk AS $11,953.43 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993055
Principal investigator 1 Novo Nordisk AS $187.50 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811303087
Principal investigator 1 Novo Nordisk AS $7,130.98 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595947
Principal investigator 1 Novo Nordisk AS $6,004.96 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829775
Principal investigator 1 Novo Nordisk AS $651.35 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833887
Principal investigator 1 Novo Nordisk AS $23.06 08/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857817
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292719
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292729
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595255
Principal investigator 1 Novo Nordisk AS $180.64 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9932-4737 No dispute reported 06/30/2026 811791545
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837243
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837245
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863001
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863003
Principal investigator 1 Novo Nordisk AS $160.00 08/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863005
Principal investigator 1 PFIZER INC. $1,722.60 08/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832599646
Principal investigator 1 PFIZER INC. $5,936.37 08/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832704787
Principal investigator 1 PFIZER INC. $373,581.45 08/21/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832617805
Principal investigator 1 Novo Nordisk AS $23.06 08/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428071
Principal investigator 1 Novo Nordisk AS $180.64 08/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811687157
Principal investigator 1 Novo Nordisk AS $180.64 08/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811791731
Principal investigator 1 Novo Nordisk AS $8.25 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804931
Principal investigator 1 Novo Nordisk AS $8.25 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804951
Principal investigator 1 Novo Nordisk AS $83.65 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993027
Principal investigator 1 Novo Nordisk AS $8.25 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679999
Principal investigator 1 Novo Nordisk AS $8.25 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680005
Principal investigator 1 Novo Nordisk AS $8.25 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680011
Principal investigator 1 Novo Nordisk AS $83.65 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811699095
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $29,179.48 08/16/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793108219
Principal investigator 1 PFIZER INC. $1,655.32 08/14/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832778507
Principal investigator 1 Novo Nordisk AS $23.06 08/13/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789145
Principal investigator 1 Novo Nordisk AS $23.06 08/13/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242035
Principal investigator 1 Novo Nordisk AS $23.06 08/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711607
Principal investigator 1 PFIZER INC. $917.00 08/11/2021 Non-covered Recipient Entity
ACCELLACARE
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 23 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED PF07321332RITONAVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT PARTICIPANTS WITH COVID19 WHO ARE AT INCREASED RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 832775885
Recipient PFIZER INC. $3,200.00 08/10/2021 Covered Recipient Physician PNEUMOCOCCAL CONJ PNG CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 832531879
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023571
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023597
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023599
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023679
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023681
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023683
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023685
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023687
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023689
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023691
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023693
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023695
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023697
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023699
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023701
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023703
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.58 08/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023705
Principal investigator 1 PFIZER INC. $1,642.95 08/06/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600507
Recipient PFIZER INC. $1,400.00 08/05/2021 Covered Recipient Physician PNEUMOCOCCAL CONJ PNG CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 832531869
Principal investigator 1 PFIZER INC. $276.23 08/03/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832695115
Principal investigator 1 Novo Nordisk AS $23.06 08/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099139
Principal investigator 1 Boehringer Ingelheim France S.A.S. $94.95 08/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023575
Principal investigator 1 Boehringer Ingelheim France S.A.S. $94.95 08/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023613
Principal investigator 1 Boehringer Ingelheim France S.A.S. $81.13 08/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023661
Principal investigator 1 Novo Nordisk AS $15,527.20 08/01/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650671
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128661
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128675
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465733
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808691
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808693
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808695
Principal investigator 1 Novo Nordisk AS $70.00 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829771
Principal investigator 1 Novo Nordisk AS $70.44 07/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842131
Principal investigator 1 Novo Nordisk AS $29.00 07/30/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894341
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650139
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650145
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650151
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650157
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650677
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650683
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650689
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650695
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650701
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650707
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650713
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650719
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650937
Principal investigator 1 Novo Nordisk AS $43.89 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650959
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650965
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650973
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650979
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650985
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650991
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811650997
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651003
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651009
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651015
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651021
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651025
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651031
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651037
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811651043
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652135
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652141
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652205
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652211
Principal investigator 1 Novo Nordisk AS $90.00 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652219
Principal investigator 1 Novo Nordisk AS $54.00 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652223
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652229
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811652235
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780821
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780823
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780861
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780863
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780889
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780891
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780893
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780895
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780969
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780971
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780983
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780985
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780987
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780989
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780991
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780993
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780995
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780997
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811780999
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781105
Principal investigator 1 Novo Nordisk AS $13.50 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811781107
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871373
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871375
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871377
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871401
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871403
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871405
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871407
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871409
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871411
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871413
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871415
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871417
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871419
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871421
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871423
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871427
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871429
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871431
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871433
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871435
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871437
Principal investigator 1 Novo Nordisk AS $7.95 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871439
Principal investigator 1 Novo Nordisk AS $13.50 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871441
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871443
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871445
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871447
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871449
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871451
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871483
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811871485
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811877775
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894267
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894269
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894271
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894299
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894301
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894303
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894305
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894307
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894309
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894311
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894313
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894315
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894323
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894325
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894327
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894329
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894331
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894333
Principal investigator 1 Novo Nordisk AS $16.23 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894363
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894365
Principal investigator 1 Novo Nordisk AS $17.07 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894367
Principal investigator 1 Novo Nordisk AS $14.97 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811894369
Principal investigator 1 Novo Nordisk AS $9.75 07/29/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811895017
Principal investigator 1 Novo Nordisk AS $23.06 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789135
Principal investigator 1 Novo Nordisk AS $23.06 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810791493
Principal investigator 1 Novo Nordisk AS $2,259.52 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299261
Principal investigator 1 Novo Nordisk AS $500.00 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811327587
Principal investigator 1 Novo Nordisk AS $8,053.17 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469331
Principal investigator 1 Novo Nordisk AS $4,415.16 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680023
Principal investigator 1 Novo Nordisk AS $7,587.00 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808683
Principal investigator 1 Novo Nordisk AS $3,015.70 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837313
Principal investigator 1 Novo Nordisk AS $1,000.00 07/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811866499
Principal investigator 1 Boehringer Ingelheim France S.A.S. $1,964.42 07/27/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023791
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465723
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808677
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808679
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808681
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842111
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842113
Principal investigator 1 Novo Nordisk AS $160.00 07/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842115
Principal investigator 1 Novo Nordisk AS $13,729.48 07/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413051
Principal investigator 1 Novo Nordisk AS $374.36 07/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857821
Principal investigator 1 PFIZER INC. $8,561.07 07/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832904061
Principal investigator 1 PFIZER INC. $13,130.78 07/22/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832617975
Principal investigator 1 Novo Nordisk AS $23.06 07/21/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789125
Principal investigator 1 PFIZER INC. $243.00 07/21/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832599655
Principal investigator 1 Novo Nordisk AS $23.06 07/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299317
Principal investigator 1 Novo Nordisk AS $1,320.00 07/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537121
Principal investigator 1 Novo Nordisk AS $23.06 07/20/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829765
Principal investigator 1 Novo Nordisk AS $23.06 07/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811303105
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $298,241.71 07/19/2021 Non-covered Recipient Entity
PMG RESEARCH
A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793106631
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $41,804.36 07/15/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793106307
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $8,491.91 07/15/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793106309
Principal investigator 1 Novo Nordisk AS $49,351.35 07/14/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811635445
Principal investigator 1 Novo Nordisk AS $2,310.00 07/14/2021 Non-covered Recipient Entity
ACCELACARE OF WILMINGTON, LLC
NN9838-4862 No dispute reported 06/30/2026 811895019
Principal investigator 1 PFIZER INC. $2,070.18 07/14/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832784751
Recipient PFIZER INC. $940.00 07/12/2021 Covered Recipient Physician PNEUMOCOCCAL CONJ PNG CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 832532109
Principal investigator 1 Novo Nordisk AS $46.12 07/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099125
Principal investigator 1 PFIZER INC. $4,081.05 07/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600137
Principal investigator 1 PFIZER INC. $10,500.00 07/09/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 MASTER PROTOCOL TO EVALUATE ADDITIONAL DOSES OF BNT162B2 IN HEALTHY INDIVIDUALS PREVIOUSLY VACCINATED WITH BNT162B2 No dispute reported 06/30/2026 832617093
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023799
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023801
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023803
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023805
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023807
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023809
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023811
Principal investigator 1 Boehringer Ingelheim France S.A.S. $34.76 07/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023813
Principal investigator 1 Novo Nordisk AS $23.06 07/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810791483
Principal investigator 1 Novo Nordisk AS $24.56 07/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537101
Principal investigator 1 Novo Nordisk AS $23.06 07/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829763
Principal investigator 1 Novo Nordisk AS $23.06 07/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857815
Principal investigator 1 GlaxoSmithKline, LLC. $17,706.34 07/02/2021 Non-covered Recipient Entity
PMG RESEARCH LLC
Not supplied No dispute reported 06/30/2026 809536625
Principal investigator 1 GlaxoSmithKline, LLC. $6,000.00 07/02/2021 Non-covered Recipient Entity
PMG RESEARCH LLC
Not supplied No dispute reported 06/30/2026 809536637
Principal investigator 1 Boehringer Ingelheim France S.A.S. $81.05 07/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023603
Principal investigator 1 Novo Nordisk AS $23.06 06/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711589
Principal investigator 1 Novo Nordisk AS $70.00 06/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798807
Principal investigator 1 PFIZER INC. $1,103.89 06/30/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832830543
Principal investigator 1 Eli Lilly and Company $307,374.00 06/29/2021 Non-covered Recipient Entity
PIEDMONT MEDICAL RESEARCH ASSOCIATES INC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATION THERAPY WITH MONOCLONAL ANTIBODIES IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS (BLAZE-4) No dispute reported 06/30/2026 819464873
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $253,312.19 06/28/2021 Non-covered Recipient Entity
PMG Research Inc
Ph IIb dose finding vs placebo in patients with Ob No dispute reported 06/30/2026 840492569
Principal investigator 1 Novo Nordisk AS $23.06 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789105
Principal investigator 1 Novo Nordisk AS $2,982.71 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789161
Principal investigator 1 Novo Nordisk AS $9,047.56 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469407
Principal investigator 1 Novo Nordisk AS $6,393.53 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537437
Principal investigator 1 Novo Nordisk AS $374.36 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811544161
Principal investigator 1 Novo Nordisk AS $5,668.59 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798809
Principal investigator 1 Novo Nordisk AS $2,453.62 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808751
Principal investigator 1 Novo Nordisk AS $5,952.38 06/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863155
Principal investigator 1 PFIZER INC. $696.28 06/28/2021 Non-covered Recipient Entity
PMG Research of WilmingtonLLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832730289
Principal investigator 1 PFIZER INC. $2,668.95 06/26/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617985
Principal investigator 1 Novo Nordisk AS $2,934.31 06/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811216725
Principal investigator 1 Novo Nordisk AS $19.00 06/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808605
Principal investigator 1 Novo Nordisk AS $394.00 06/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842055
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $2,590.89 06/24/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830756221
Principal investigator 1 Boehringer Ingelheim France S.A.S. $276.44 06/24/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023601
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $1,860.80 06/24/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 EX 14870 Ph III in SARS Cov 2 Preventi No dispute reported 06/30/2026 840494697
Principal investigator 1 GlaxoSmithKline, LLC. $14,901.10 06/23/2021 Non-covered Recipient Entity
PMG RESEARCH INC
Not supplied No dispute reported 06/30/2026 809490311
Principal investigator 1 Novo Nordisk AS $24.56 06/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680931
Principal investigator 1 PFIZER INC. $26,832.60 06/23/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832617795
Principal investigator 1 PFIZER INC. $44,770.18 06/23/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832618607
Principal investigator 1 PFIZER INC. $1,154.28 06/23/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832764791
Principal investigator 1 PFIZER INC. $2,727.66 06/23/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832884905
Principal investigator 1 Novo Nordisk AS $24.56 06/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680937
Principal investigator 1 PFIZER INC. $827.66 06/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832760589
Principal investigator 1 Novo Nordisk AS $23.06 06/21/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299291
Principal investigator 1 Novo Nordisk AS $23.06 06/18/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789095
Principal investigator 1 Novo Nordisk AS $23.06 06/18/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428031
Principal investigator 1 Novo Nordisk AS $23.06 06/17/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099115
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $57,075.10 06/17/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793104365
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37,524.04 06/17/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793104367
Principal investigator 1 PFIZER INC. $10,500.00 06/15/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED DOUBLE BLIND TRIAL TO DESCRIBE THE SAFETY AND IMMUNOGENICITY OF 20 VALENT PNEUMOCOCCAL CONJUGATE VACCINE WHEN COADMINISTERED WITH A BOOSTER DOSE OF BNT162B2 IN ADULTS 65 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832616971
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $31.82 06/14/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752987
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $16.20 06/14/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754845
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $189.45 06/14/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755759
Principal investigator 1 Novo Nordisk AS $394.00 06/14/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465561
Principal investigator 1 Novo Nordisk AS $19.00 06/14/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808603
Principal investigator 1 PFIZER INC. $2,230.90 06/12/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832872804
Principal investigator 1 Novo Nordisk AS $14.82 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128503
Principal investigator 1 Novo Nordisk AS $19.95 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128517
Principal investigator 1 Novo Nordisk AS $3.25 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128531
Principal investigator 1 Novo Nordisk AS $2.65 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465371
Principal investigator 1 Novo Nordisk AS $55.38 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465545
Principal investigator 1 Novo Nordisk AS $2.34 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465555
Principal investigator 1 Novo Nordisk AS $4.87 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808599
Principal investigator 1 Novo Nordisk AS $20.00 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808601
Principal investigator 1 Novo Nordisk AS $4.00 06/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842053
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $31.82 06/09/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752977
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3.76 06/09/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753673
Principal investigator 1 Novo Nordisk AS $23.06 06/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789085
Principal investigator 1 PFIZER INC. $2,205.55 06/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832784675
Principal investigator 1 PFIZER INC. $3,655.22 06/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832817807
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $0.94 06/08/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754903
Principal investigator 1 Novo Nordisk AS $23.06 06/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711597
Principal investigator 1 Boehringer Ingelheim France S.A.S. $357.67 06/06/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023617
Principal investigator 1 PFIZER INC. $1,327.05 06/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832605789
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $4.35 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830751911
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $529.20 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752015
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $78.40 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752373
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $228.29 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752925
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3,803.55 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753177
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $23.29 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753233
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $2.88 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753307
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $24.80 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754053
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $201.18 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755057
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $171.73 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755163
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $0.69 06/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755667
Principal investigator 1 Novo Nordisk AS $23.06 06/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811443505
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $7.86 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830751571
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $80.87 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752583
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $315.44 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753481
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $756.79 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753789
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $0.78 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754749
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $27.17 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755797
Principal investigator 1 Boehringer Ingelheim France S.A.S. $83.63 06/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023579
Principal investigator 1 Novo Nordisk AS $70.00 05/31/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829769
Principal investigator 1 PFIZER INC. $4,519.65 05/29/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832720931
Principal investigator 1 Novo Nordisk AS $4,968.78 05/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799249
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $80.35 05/26/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830756219
Principal investigator 1 Boehringer Ingelheim France S.A.S. $305.84 05/26/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023659
Principal investigator 1 Novo Nordisk AS $2,046.09 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099191
Principal investigator 1 Novo Nordisk AS $6,861.98 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293833
Principal investigator 1 Novo Nordisk AS $3,986.74 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299367
Principal investigator 1 Novo Nordisk AS $400.00 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811327615
Principal investigator 1 Novo Nordisk AS $374.36 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811544141
Principal investigator 1 Novo Nordisk AS $10,907.19 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680949
Principal investigator 1 Novo Nordisk AS $3,772.69 05/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811809393
Principal investigator 1 PFIZER INC. $54,268.65 05/25/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617159
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127971
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127985
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127999
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128477
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128491
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128597
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128609
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128621
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128633
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128647
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811136861
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465351
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465361
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465667
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465677
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465687
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465697
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465707
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465717
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465753
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465763
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808589
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808591
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808593
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808595
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808597
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808671
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808673
Principal investigator 1 Novo Nordisk AS $12.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808675
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808689
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842041
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842043
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842045
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842047
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842049
Principal investigator 1 Novo Nordisk AS $120.00 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842051
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842069
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842109
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842125
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842127
Principal investigator 1 Novo Nordisk AS $1.12 05/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842129
Principal investigator 1 PFIZER INC. $2,654.10 05/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604965
Principal investigator 1 PFIZER INC. $3,193.49 05/22/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832870795
Principal investigator 1 Novo Nordisk AS $23.06 05/21/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428061
Principal investigator 1 PFIZER INC. $5,771.40 05/21/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832897195
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $13,837.03 05/21/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTI-DOSE STUDY IN PATIENTS WITH MODERATE-TO-SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP TO ASSESS THE PATIENTS' ABILITY TO SELF-ADMINISTER FASINUMAB USING AN AUTO-INJECTOR AND TO CHARACTERIZE THE PHARMACOKINETICS OF FASINUMAB USING TWO DIFFERENT PRESENTATIONS No dispute reported 06/30/2026 793102679
Principal investigator 1 Eli Lilly and Company $13,024.24 05/18/2021 Non-covered Recipient Entity
PIEDMONT MEDICAL RESEARCH ASSOCIATES INC
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATION THERAPY WITH MONOCLONAL ANTIBODIES IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS (BLAZE-4) No dispute reported 06/30/2026 819462983
Principal investigator 1 PFIZER INC. $9,406.80 05/18/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832617759
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3,803.55 05/17/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830751589
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $300.48 05/17/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753861
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $16.20 05/17/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754767
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33,367.05 05/17/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793102459
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $23,407.09 05/17/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793102461
Principal investigator 1 PFIZER INC. $9,601.88 05/15/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832810497
Principal investigator 1 Novo Nordisk AS $23.06 05/14/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811446975
Principal investigator 1 PFIZER INC. $100.00 05/14/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832735671
Principal investigator 1 PFIZER INC. $2,490.00 05/14/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832812945
Principal investigator 1 PFIZER INC. $130.00 05/14/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832842801
Principal investigator 1 PFIZER INC. $750.00 05/14/2021 Non-covered Recipient Entity
ACCELLACARE US INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832912823
Principal investigator 1 PFIZER INC. $1,998.00 05/13/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600127
Principal investigator 1 Novo Nordisk AS $23.06 05/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810713655
Principal investigator 1 SANOFI US SERVICES INC. $2,300.00 05/12/2021 Non-covered Recipient Entity
Pmg Research,Inc DBA Pmg Research Of Charleston,LLC
A 56-week, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise No dispute reported 06/30/2026 838660877
Principal investigator 1 SANOFI US SERVICES INC. $3,500.00 05/12/2021 Non-covered Recipient Entity
Pmg Research,Inc DBA Pmg Research Of Charleston,LLC
A 56-week, Multicenter, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of Efpeglenatide Once Weekly in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Diet and Exercise No dispute reported 06/30/2026 838660879
Principal investigator 1 Novo Nordisk AS $500.00 05/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4506 No dispute reported 06/30/2026 811330293
Principal investigator 1 Novo Nordisk AS $2,003.90 05/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4506 No dispute reported 06/30/2026 811866507
Principal investigator 1 Novo Nordisk AS $750.00 05/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4506 No dispute reported 06/30/2026 811866509
Principal investigator 1 PFIZER INC. $696.28 05/10/2021 Non-covered Recipient Entity
PMG Research of WilmingtonLLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832760009
Principal investigator 1 PFIZER INC. $18,268.20 05/08/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832617769
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $59.00 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830751701
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $660.00 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830751951
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $529.20 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752023
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $4.35 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752299
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $4.70 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752393
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $676.88 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752541
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3,803.55 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752871
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $25.02 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752947
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $23.29 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753139
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $2.88 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753401
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $21.05 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753725
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $218.44 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754129
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $24.80 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830754327
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $171.73 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755183
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $1,140.00 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755201
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3,772.09 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755323
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $0.69 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755565
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $3,772.09 05/07/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830755821
Principal investigator 1 PFIZER INC. $10,196.14 05/07/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832749539
Principal investigator 1 Boehringer Ingelheim France S.A.S. $176.61 05/05/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023615
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $306.00 05/05/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 EX14870 Ph II III SARS COV 2 Ambulato No dispute reported 06/30/2026 840490817
Principal investigator 1 Novo Nordisk AS $23.06 05/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810789115
Principal investigator 1 PFIZER INC. $3,467.01 05/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832723833
Principal investigator 1 Boehringer Ingelheim France S.A.S. $82.21 05/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023797
Principal investigator 1 PFIZER INC. $52,297.65 05/01/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832617587
Principal investigator 1 PFIZER INC. $10,708.17 05/01/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832828467
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $56.02 04/30/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752431
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $421.44 04/30/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830752791
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $28.65 04/30/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830753245
Principal investigator 1 Novo Nordisk AS $70.00 04/30/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829761
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,454.84 04/29/2021 Non-covered Recipient Entity
PMG RESEARCH
A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793101781
Principal investigator 1 Novo Nordisk AS $23.06 04/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428041
Principal investigator 1 Boehringer Ingelheim Canada Ltd.Ltee $1,015.79 04/27/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV No dispute reported 06/30/2026 830756217
Principal investigator 1 Novo Nordisk AS $23.06 04/27/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428051
Principal investigator 1 Novo Nordisk AS $5,010.65 04/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721271
Principal investigator 1 Novo Nordisk AS $23.06 04/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413033
Principal investigator 1 PFIZER INC. $696.28 04/26/2021 Non-covered Recipient Entity
PMG Research of WilmingtonLLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832778731
Principal investigator 1 PFIZER INC. $460.35 04/24/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832617149
Principal investigator 1 PFIZER INC. $15,499.06 04/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832865389
Principal investigator 1 Novo Nordisk AS $11,764.58 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 810968911
Principal investigator 1 Novo Nordisk AS $2,480.69 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992471
Principal investigator 1 Novo Nordisk AS $7,192.12 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413061
Principal investigator 1 Novo Nordisk AS $3,938.65 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811428663
Principal investigator 1 Novo Nordisk AS $3,000.00 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811464319
Principal investigator 1 Novo Nordisk AS $3,000.00 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680943
Principal investigator 1 Novo Nordisk AS $2,979.75 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811834327
Principal investigator 1 Novo Nordisk AS $4,462.05 04/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837335
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292423
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292433
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292443
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292453
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292641
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292651
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292661
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292671
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292699
Principal investigator 1 Novo Nordisk AS $0.30 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292709
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293001
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293011
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293021
Principal investigator 1 Novo Nordisk AS $33.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293029
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293037
Principal investigator 1 Novo Nordisk AS $394.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293047
Principal investigator 1 Novo Nordisk AS $108.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293057
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293067
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293075
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293085
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293094
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293101
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293109
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293311
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293321
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293331
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293339
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293347
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293357
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293367
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293373
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293383
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293392
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293399
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293409
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293419
Principal investigator 1 Novo Nordisk AS $891.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537429
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595013
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595023
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595031
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595041
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595341
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595351
Principal investigator 1 Novo Nordisk AS $162.90 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595361
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595371
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595381
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595391
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595400
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595411
Principal investigator 1 Novo Nordisk AS $19.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595421
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595429
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595437
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595447
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595457
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595467
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595477
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595487
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595497
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595533
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595543
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595553
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595899
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595908
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595917
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595927
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811603497
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837231
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837233
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837235
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837239
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837241
Principal investigator 1 Novo Nordisk AS $4.53 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837265
Principal investigator 1 Novo Nordisk AS $2.86 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837267
Principal investigator 1 Novo Nordisk AS $24.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837269
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837271
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837273
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837275
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837277
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837287
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837289
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837291
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837293
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837295
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837297
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837299
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837301
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837303
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837305
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837307
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837309
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862951
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862953
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862955
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862995
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862997
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862999
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863023
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863025
Principal investigator 1 Novo Nordisk AS $594.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863027
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863029
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863079
Principal investigator 1 Novo Nordisk AS $7.95 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863081
Principal investigator 1 Novo Nordisk AS $4.50 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863083
Principal investigator 1 Novo Nordisk AS $5.98 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863085
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863087
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863089
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863091
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863093
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863095
Principal investigator 1 Novo Nordisk AS $14.97 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863097
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863099
Principal investigator 1 Novo Nordisk AS $9.75 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863101
Principal investigator 1 Novo Nordisk AS $14.61 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863103
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863143
Principal investigator 1 Novo Nordisk AS $240.00 04/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863145
Principal investigator 1 Novo Nordisk AS $23.06 04/21/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711531
Principal investigator 1 PFIZER INC. $6,540.92 04/21/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832711077
Principal investigator 1 PFIZER INC. $29,644.65 04/20/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617785
Principal investigator 1 Novo Nordisk AS $23.06 04/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711521
Principal investigator 1 Novo Nordisk AS $23.06 04/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811303077
Principal investigator 1 Novo Nordisk AS $46.12 04/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798761
Principal investigator 1 PFIZER INC. $22,695.54 04/17/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832892049
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804865
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804885
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804895
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804905
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804915
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804921
Principal investigator 1 Novo Nordisk AS $12.00 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804941
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805097
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805107
Principal investigator 1 Novo Nordisk AS $14.61 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805117
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810811313
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992647
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992661
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992673
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992685
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992945
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992957
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992971
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992985
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992999
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993013
Principal investigator 1 Novo Nordisk AS $4.53 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993041
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993443
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993456
Principal investigator 1 Novo Nordisk AS $9.75 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993469
Principal investigator 1 Novo Nordisk AS $108.00 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811010543
Principal investigator 1 Novo Nordisk AS $8.58 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537041
Principal investigator 1 Novo Nordisk AS $7.95 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537051
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537081
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537091
Principal investigator 1 Novo Nordisk AS $59.85 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537111
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537389
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537399
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537409
Principal investigator 1 Novo Nordisk AS $60.00 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537419
Principal investigator 1 Novo Nordisk AS $488.70 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679959
Principal investigator 1 Novo Nordisk AS $657.00 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679965
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679983
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679987
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679993
Principal investigator 1 Novo Nordisk AS $4.50 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680017
Principal investigator 1 Novo Nordisk AS $0.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680919
Principal investigator 1 Novo Nordisk AS $13.25 04/16/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680925
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $53,083.49 04/15/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793100795
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $581,273.05 04/15/2021 Non-covered Recipient Entity
PMG RESEARCH
A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793100799
Principal investigator 1 PFIZER INC. $1,215.00 04/14/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600955
Principal investigator 1 PFIZER INC. $10,500.00 04/10/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE FORMULATIONS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID 19 IN HEALTHY ADULTS 18 THROUGH 55 YEARS OF AGE No dispute reported 06/30/2026 832623573
Principal investigator 1 PFIZER INC. $37,280.14 04/10/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832811075
Principal investigator 1 PFIZER INC. $1,871.10 04/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604983
Principal investigator 1 PFIZER INC. $1,731.42 04/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832784759
Principal investigator 1 Novo Nordisk AS $23.06 04/07/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811427991
Principal investigator 1 Novo Nordisk AS $23.06 04/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811427981
Principal investigator 1 Novo Nordisk AS $6.26 04/06/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829753
Principal investigator 1 Boehringer Ingelheim France S.A.S. $172.87 04/04/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023657
Principal investigator 1 PFIZER INC. $3,527.55 04/03/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617995
Principal investigator 1 PFIZER INC. $27,376.89 04/03/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832724511
Principal investigator 1 Boehringer Ingelheim France S.A.S. $80.16 04/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023671
Principal investigator 1 Novo Nordisk AS $23.06 04/01/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811427971
Principal investigator 1 Novo Nordisk AS $70.00 03/31/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099181
Principal investigator 1 Novo Nordisk AS $20.25 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099035
Principal investigator 1 Novo Nordisk AS $7.95 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099049
Principal investigator 1 Novo Nordisk AS $13.50 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099063
Principal investigator 1 Novo Nordisk AS $4,833.72 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299357
Principal investigator 1 Novo Nordisk AS $23.06 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811303067
Principal investigator 1 Novo Nordisk AS $9.75 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811412985
Principal investigator 1 Novo Nordisk AS $13.50 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798757
Principal investigator 1 Novo Nordisk AS $54.00 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798759
Principal investigator 1 Novo Nordisk AS $90.00 03/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829751
Principal investigator 1 PFIZER INC. $79,957.80 03/27/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617775
Principal investigator 1 PFIZER INC. $31,778.75 03/27/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832699971
Principal investigator 1 Boehringer Ingelheim France S.A.S. $1,600.30 03/25/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023673
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $400.00 03/25/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793099525
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721261
Principal investigator 1 Novo Nordisk AS $1,930.29 03/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293793
Principal investigator 1 Novo Nordisk AS $17,690.08 03/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469399
Principal investigator 1 Novo Nordisk AS $14,190.65 03/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811751039
Principal investigator 1 Novo Nordisk AS $3,000.00 03/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829747
Principal investigator 1 PFIZER INC. $2,478.60 03/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600965
Principal investigator 1 PFIZER INC. $31,747.95 03/24/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617577
Principal investigator 1 Novo Nordisk AS $23.06 03/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711503
Principal investigator 1 PFIZER INC. $40,838.70 03/20/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832843835
Principal investigator 1 Novo Nordisk AS $23.06 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711511
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292367
Principal investigator 1 Novo Nordisk AS $878.40 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292377
Principal investigator 1 Novo Nordisk AS $2.44 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292387
Principal investigator 1 Novo Nordisk AS $22.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292397
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292403
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292413
Principal investigator 1 Novo Nordisk AS $40.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292991
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293119
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293127
Principal investigator 1 Novo Nordisk AS $5.72 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293137
Principal investigator 1 Novo Nordisk AS $651.60 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811293145
Principal investigator 1 Novo Nordisk AS $23.06 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299231
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811594987
Principal investigator 1 Novo Nordisk AS $3.02 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811594993
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595003
Principal investigator 1 Novo Nordisk AS $72.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595303
Principal investigator 1 Novo Nordisk AS $9.74 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595313
Principal investigator 1 Novo Nordisk AS $0.30 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595323
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595331
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595503
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595513
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811595523
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837217
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837219
Principal investigator 1 Novo Nordisk AS $1,485.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837221
Principal investigator 1 Novo Nordisk AS $788.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837223
Principal investigator 1 Novo Nordisk AS $5.30 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837225
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837227
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837229
Principal investigator 1 Novo Nordisk AS $8.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837261
Principal investigator 1 Novo Nordisk AS $3.00 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837263
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837279
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837281
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837283
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811837285
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862939
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862941
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862943
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862945
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862947
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811862949
Principal investigator 1 Novo Nordisk AS $39.90 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863019
Principal investigator 1 Novo Nordisk AS $6.50 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863021
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863069
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863071
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863073
Principal investigator 1 Novo Nordisk AS $2.65 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863075
Principal investigator 1 Novo Nordisk AS $3.02 03/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811863077
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33,372.95 03/18/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793099061
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $335,674.11 03/18/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793099067
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $124,424.48 03/16/2021 Non-covered Recipient Entity
PMG Research Inc
Phase II study of BI456906 in Patients with T2DM O No dispute reported 06/30/2026 840492557
Principal investigator 1 PFIZER INC. $696.28 03/16/2021 Non-covered Recipient Entity
PMG Research of WilmingtonLLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832843841
Principal investigator 1 Novo Nordisk AS $180.64 03/15/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798755
Principal investigator 1 PFIZER INC. $16,256.70 03/13/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832617957
Principal investigator 1 PFIZER INC. $73,880.73 03/13/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832760311
Principal investigator 1 PFIZER INC. $142,697.70 03/12/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832618569
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $68,699.19 03/12/2021 Non-covered Recipient Entity
PMG RESEARCH INC
PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NSAID CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP No dispute reported 06/30/2026 793098571
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127815
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127827
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127841
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127851
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127863
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127874
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127887
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127901
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127915
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811127929
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128569
Principal investigator 1 Novo Nordisk AS $28.47 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811128583
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811464325
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811464335
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811464345
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811464355
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465195
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465205
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465215
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465225
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465235
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465245
Principal investigator 1 Novo Nordisk AS $14.61 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465255
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465631
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465641
Principal investigator 1 Novo Nordisk AS $44.46 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465651
Principal investigator 1 Novo Nordisk AS $7.02 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465661
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811479027
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808373
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808375
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808377
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808379
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808381
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808383
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808385
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808387
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808389
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808391
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808393
Principal investigator 1 Novo Nordisk AS $59.85 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808395
Principal investigator 1 Novo Nordisk AS $60.00 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808397
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808399
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808661
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808663
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808665
Principal investigator 1 Novo Nordisk AS $7.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808667
Principal investigator 1 Novo Nordisk AS $166.14 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811808669
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842019
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842021
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842023
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842025
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842027
Principal investigator 1 Novo Nordisk AS $4.99 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842029
Principal investigator 1 Novo Nordisk AS $9.75 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842031
Principal investigator 1 Novo Nordisk AS $1.95 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842033
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842061
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842063
Principal investigator 1 Novo Nordisk AS $7.50 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842065
Principal investigator 1 Novo Nordisk AS $12.00 03/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811842067
Principal investigator 1 Novo Nordisk AS $23.06 03/10/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536935
Principal investigator 1 Novo Nordisk AS $23.06 03/09/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811427961
Principal investigator 1 Novo Nordisk AS $2,784.34 03/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4481 No dispute reported 06/30/2026 811465773
Principal investigator 1 Novo Nordisk AS $1,066.14 03/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811686847
Principal investigator 1 Novo Nordisk AS $369.00 03/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811693183
Principal investigator 1 Novo Nordisk AS $1,066.14 03/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811880781
Principal investigator 1 Novo Nordisk AS $369.00 03/08/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4578 No dispute reported 06/30/2026 811900849
Principal investigator 1 PFIZER INC. $1,819.80 03/06/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832600487
Principal investigator 1 PFIZER INC. $456,814.97 03/06/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832721283
Principal investigator 1 Novo Nordisk AS $70.86 03/05/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799123
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 03/05/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTI-DOSE STUDY IN PATIENTS WITH MODERATE-TO-SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP TO ASSESS THE PATIENTS' ABILITY TO SELF-ADMINISTER FASINUMAB USING AN AUTO-INJECTOR AND TO CHARACTERIZE THE PHARMACOKINETICS OF FASINUMAB USING TWO DIFFERENT PRESENTATIONS No dispute reported 06/30/2026 793097889
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 03/05/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTI-DOSE STUDY IN PATIENTS WITH MODERATE-TO-SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP TO ASSESS THE PATIENTS' ABILITY TO SELF-ADMINISTER FASINUMAB USING AN AUTO-INJECTOR AND TO CHARACTERIZE THE PHARMACOKINETICS OF FASINUMAB USING TWO DIFFERENT PRESENTATIONS No dispute reported 06/30/2026 793097891
Principal investigator 1 Novo Nordisk AS $23.06 03/04/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810713625
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $3,031,652.24 03/04/2021 Non-covered Recipient Entity
PMG RESEARCH
A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793097825
Principal investigator 1 Boehringer Ingelheim France S.A.S. $177.65 03/03/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023665
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $960.40 03/03/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Ob No dispute reported 06/30/2026 840494695
Principal investigator 1 PFIZER INC. $29,869.30 03/03/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLIND STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MULTIPLE PRODUCTION LOTS AND DOSE LEVELS OF THE VACCINE CANDIDATE BNT162B2 AGAINST COVID19 IN HEALTHY PARTICIPANTS 12 THROUGH 50YEARS OF AGE AND THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BNT162B2 RNABASED COVID19 VACCINE CANDIDATES AS A BOOSTER DOSE IN HEALTHY PARTICIPANTS 18 THROUGH 50YEARS OF AGE No dispute reported 06/30/2026 832616955
Principal investigator 1 Novo Nordisk AS $23.06 03/02/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811833891
Principal investigator 1 Boehringer Ingelheim France S.A.S. $82.64 03/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023669
Principal investigator 1 PFIZER INC. $2,612.38 02/27/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832718609
Principal investigator 1 Novo Nordisk AS $70.00 02/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099103
Principal investigator 1 Novo Nordisk AS $200.00 02/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 811469389
Principal investigator 1 Novo Nordisk AS $250.00 02/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811834323
Principal investigator 1 Novo Nordisk AS $5.72 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992485
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811602733
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603095
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603103
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603113
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603123
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603131
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603141
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603151
Principal investigator 1 Novo Nordisk AS $6.50 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603161
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603171
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603180
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603189
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603199
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603209
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603219
Principal investigator 1 Novo Nordisk AS $6.08 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811603227
Principal investigator 1 Novo Nordisk AS $0.20 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679211
Principal investigator 1 Novo Nordisk AS $325.80 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679217
Principal investigator 1 Novo Nordisk AS $438.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679275
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770361
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770363
Principal investigator 1 Novo Nordisk AS $3.20 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770365
Principal investigator 1 Novo Nordisk AS $11.20 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770367
Principal investigator 1 Novo Nordisk AS $39.90 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770369
Principal investigator 1 Novo Nordisk AS $9.74 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770371
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770373
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770375
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770377
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770379
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770381
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770383
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770425
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770427
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811770429
Principal investigator 1 Novo Nordisk AS $23.06 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811857825
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867879
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867881
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867883
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867885
Principal investigator 1 Novo Nordisk AS $0.64 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867887
Principal investigator 1 Novo Nordisk AS $40.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867889
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867893
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867895
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867897
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867899
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867901
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867903
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867941
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811867943
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890879
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890881
Principal investigator 1 Novo Nordisk AS $1.95 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890883
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890885
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890887
Principal investigator 1 Novo Nordisk AS $5.30 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890889
Principal investigator 1 Novo Nordisk AS $8.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890891
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890893
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890895
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890897
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890899
Principal investigator 1 Novo Nordisk AS $3.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890901
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811890903
Principal investigator 1 Novo Nordisk AS $9.98 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4479 No dispute reported 06/30/2026 811891019
Principal investigator 1 PFIZER INC. $65.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832689893
Principal investigator 1 PFIZER INC. $1,125.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832741061
Principal investigator 1 PFIZER INC. $150.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832760595
Principal investigator 1 PFIZER INC. $23,500.00 02/25/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 3 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832912381
Principal investigator 1 Novo Nordisk AS $260.00 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711637
Principal investigator 1 Novo Nordisk AS $7,811.83 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711645
Principal investigator 1 Novo Nordisk AS $13,707.94 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 811216715
Principal investigator 1 Novo Nordisk AS $871.33 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811246461
Principal investigator 1 Novo Nordisk AS $3,585.06 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4477 No dispute reported 06/30/2026 811292357
Principal investigator 1 Novo Nordisk AS $250.00 02/24/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811304369
Principal investigator 1 PFIZER INC. $2,424.60 02/24/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832605395
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804739
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804749
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804759
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804769
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804779
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804789
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804799
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804806
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804817
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804825
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804837
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804847
Principal investigator 1 Novo Nordisk AS $5.30 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804855
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810804875
Principal investigator 1 Novo Nordisk AS $18.25 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805001
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805011
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805021
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805031
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805041
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805051
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805061
Principal investigator 1 Novo Nordisk AS $72.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805067
Principal investigator 1 Novo Nordisk AS $39.90 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805077
Principal investigator 1 Novo Nordisk AS $6.50 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810805087
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810811323
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810811331
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992499
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992511
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992523
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992537
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992551
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992565
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992579
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992593
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992607
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992621
Principal investigator 1 Novo Nordisk AS $3.02 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810992635
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993069
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993083
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993097
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993111
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993126
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993139
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993153
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993167
Principal investigator 1 Novo Nordisk AS $8.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993181
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 810993431
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536745
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536755
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536765
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536774
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536783
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536794
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536803
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536813
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536823
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811536833
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537013
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537021
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537031
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537061
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537071
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537151
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537161
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537169
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537177
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537361
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537369
Principal investigator 1 Novo Nordisk AS $9.74 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811537379
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811565875
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679223
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679229
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679235
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679241
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679247
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679251
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679259
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679263
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679269
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679281
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679287
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679291
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679297
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679941
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679947
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679953
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679971
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811679977
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680029
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680035
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680041
Principal investigator 1 Novo Nordisk AS $3.05 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680883
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680889
Principal investigator 1 Novo Nordisk AS $9.98 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680897
Principal investigator 1 Novo Nordisk AS $3.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680902
Principal investigator 1 Novo Nordisk AS $1.95 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680907
Principal investigator 1 Novo Nordisk AS $40.00 02/23/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN1436-4478 No dispute reported 06/30/2026 811680913
Principal investigator 1 Novo Nordisk AS $3,092.52 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810799241
Principal investigator 1 Novo Nordisk AS $20.25 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811099021
Principal investigator 1 Novo Nordisk AS $644.85 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811327597
Principal investigator 1 Novo Nordisk AS $75.00 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811412965
Principal investigator 1 Novo Nordisk AS $19.17 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811412975
Principal investigator 1 Novo Nordisk AS $75.00 02/22/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829749
Principal investigator 1 PFIZER INC. $2,569.15 02/20/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832695709
Principal investigator 1 Novo Nordisk AS $23.06 02/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299221
Principal investigator 1 Novo Nordisk AS $23.06 02/19/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811536927
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $48,428.03 02/18/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793096059
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $58,171.37 02/18/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793096081
Principal investigator 1 PFIZER INC. $1,306.19 02/13/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832748283
Principal investigator 1 Novo Nordisk AS $23.06 02/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242091
Principal investigator 1 Novo Nordisk AS $23.06 02/12/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811427951
Principal investigator 1 Novo Nordisk AS $23.06 02/11/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 811299211
Principal investigator 1 PFIZER INC. $2,166.20 02/06/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832759121
Principal investigator 1 PFIZER INC. $4,849.20 02/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604975
Principal investigator 1 PFIZER INC. $4,244.40 02/05/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832775537
Principal investigator 1 GlaxoSmithKline, LLC. $500.00 02/03/2021 Non-covered Recipient Entity
PMG RESEARCH INC
Not supplied No dispute reported 06/30/2026 809490309
Principal investigator 1 Boehringer Ingelheim France S.A.S. $82.88 02/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Ph IIb dose finding vs placebo in patients with Obesity No dispute reported 06/30/2026 827023667
Principal investigator 1 PFIZER INC. $1,306.19 01/30/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832877521
Principal investigator 1 Novo Nordisk AS $70.00 01/29/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811798805
Principal investigator 1 Novo Nordisk AS $3,540.65 01/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9536-4388 No dispute reported 06/30/2026 810721139
Principal investigator 1 Novo Nordisk AS $11,372.12 01/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4576 No dispute reported 06/30/2026 810959971
Principal investigator 1 Novo Nordisk AS $967.27 01/28/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9536-4373 No dispute reported 06/30/2026 811634687
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 01/27/2021 Non-covered Recipient Entity
PMG RESEARCH INC
PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NSAID CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP No dispute reported 06/30/2026 793092975
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 01/27/2021 Non-covered Recipient Entity
PMG RESEARCH INC
PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NSAID CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP No dispute reported 06/30/2026 793092977
Principal investigator 1 Eli Lilly and Company $9,163.65 01/26/2021 Non-covered Recipient Entity
PIEDMONT MEDICAL RESEARCH ASSOCIATES INC
A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS No dispute reported 06/30/2026 819466471
Principal investigator 1 Novo Nordisk AS $381.19 01/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
EX9924-4473 No dispute reported 06/30/2026 810711493
Principal investigator 1 Novo Nordisk AS $374.36 01/26/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9535-4321 No dispute reported 06/30/2026 811242081
Principal investigator 1 PFIZER INC. $446.18 01/23/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832762423
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $202.50 01/21/2021 Non-covered Recipient Entity
PMG RESEARCH
A MASTER PROTOCOL ASSESSING THE SAFETY, TOLERABILITY, AND EFFICACY OF ANTI-SPIKE (S) SARS-COV-2 MONOCLONAL ANTIBODIES FOR THE TREATMENT OF AMBULATORY PATIENTS WITH COVID-19 No dispute reported 06/30/2026 793092467
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $52,717.18 01/21/2021 Non-covered Recipient Entity
PMG RESEARCH
A Phase 2 Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Outpatients With SARS-CoV-2 Infection No dispute reported 06/30/2026 793092469
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $40,921.97 01/18/2021 Non-covered Recipient Entity
PMG RESEARCH
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ASSESSING THE EFFICACY AND SAFETY OF ANTI-SPIKE SARS-COV-2 MONOCLONAL ANTIBODIES IN PREVENTING SARS-COV-2 INFECTION IN HOUSEHOLD CONTACTS OF INDIVIDUALS INFECTED WITH SARS-COV-2 No dispute reported 06/30/2026 793092205
Principal investigator 1 PFIZER INC. $604.80 01/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832605405
Principal investigator 1 PFIZER INC. $661.50 01/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF A RESPIRATORY SYNCYTIAL VIRUS RSV VACCINE IN HEALTHY ADULTS No dispute reported 06/30/2026 832688607
Principal investigator 1 PFIZER INC. $3,713.85 01/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832807577
Principal investigator 1 PFIZER INC. $1,306.19 01/16/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832850745
Principal investigator 1 Novo Nordisk AS $25.00 01/15/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811413071
Principal investigator 1 Novo Nordisk AS $75.00 01/15/2021 Non-covered Recipient Entity
PMG RESEARCH, INC
NN9924-4635 No dispute reported 06/30/2026 811829759
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $813.33 01/15/2021 Non-covered Recipient Entity
PMG RESEARCH INC
A PHASE 1, MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, MULTI-DOSE STUDY IN PATIENTS WITH MODERATE-TO-SEVERE PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP TO ASSESS THE PATIENTS' ABILITY TO SELF-ADMINISTER FASINUMAB USING AN AUTO-INJECTOR AND TO CHARACTERIZE THE PHARMACOKINETICS OF FASINUMAB USING TWO DIFFERENT PRESENTATIONS No dispute reported 06/30/2026 793091893
Principal investigator 1 PFIZER INC. $4,309.20 01/12/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832604643
Principal investigator 1 PFIZER INC. $8,599.50 01/12/2021 Non-covered Recipient Entity
Accellacare US Inc
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE IMMUNOGENICITY SAFETY AND TOLERABILITY OF 2 DOSES COMPARED TO 3 DOSES OF CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER No dispute reported 06/30/2026 832770527
Principal investigator 1 PFIZER INC. $22,537.15 01/09/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20VALENT PNEUMOCOCCAL CONJUGATE VACCINE 20VPNC WHEN COADMINISTERED WITH SEASONAL INACTIVATED INFLUENZA VACCINE SIIV IN ADULTS 65 YEARS OF AGE No dispute reported 06/30/2026 832714387
Principal investigator 1 PFIZER INC. $2,612.38 01/08/2021 Non-covered Recipient Entity
PMG Research Inc
A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS No dispute reported 06/30/2026 832701339
Principal investigator 1 Merck Sharp & Dohme Corporation $10,500.00 01/04/2021 Non-covered Recipient Entity
PMG RESEARCH OF WILMINGTON, LLC
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V590 rVSV G-SARS-CoV-2-S, Live in Healthy Individuals 16 Years of Age or Older No dispute reported 06/30/2026 848738985
Principal investigator 1 Merck Sharp & Dohme Corporation $2,000.00 01/04/2021 Non-covered Recipient Entity
PMG RESEARCH OF WILMINGTON, LLC
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V591 MV SARS-CoV-2, Live, Recombinant in Healthy Individuals 16 Years of Age or Older No dispute reported 06/30/2026 848760423
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $2,416.50 01/01/2021 Non-covered Recipient Entity
Pmg Research Of Wilmington
Phase II study of BI456906 in Patients with T2DM O No dispute reported 06/30/2026 840494783